Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G

This publication has 11 references indexed in Scilit:

• Characterization of the deamidase enzyme responsible for the metabolism of the anti-cancer peptide: H-Arg-d-Trp-NmePhe-d-Trp-Leu-Met-NH2
  Biochemical Pharmacology, 1995
• Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]-substance P (6—11) in nude mice bearing the H69 small-cell lung cancer xenograft
  Annals of Oncology, 1995
• Substance P-related antagonists inhibit vasopressin and bombesin but not 5?-3-O-(thio) triphosphate-stimulated inositol phosphate production in swiss 3T3 cells
  Journal of Cellular Physiology, 1995
• Metabolism of the anticancer peptide: H-Arg-d-Trp-NmePhe-d-Trp-Leu-Met-NH2
  Peptides, 1995
• Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8-substance P (6–11) characterized by high-performance liquid chromatography
  Journal of Pharmaceutical and Biomedical Analysis, 1994
• Substance P, vasoactive intestinal polypeptide, and gastrin catabolism in canine liver and kidney
  Digestive Diseases and Sciences, 1992
• In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth
  British Journal of Cancer, 1992
• Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme
  Peptides, 1991
• Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
  Nature, 1985
• Synthesis and Biological Properties of Enzyme‐Resistant Analogues of Substance P
  European Journal of Biochemistry, 1981